EPAI targets companies positioned to benefit from AI adoption reaching an inflection point — where the technology shifts from experimental to revenue-generating at scale. This isn't another generic tech fund; it's hunting for firms where AI is becoming a core profit driver.
How It Works
The fund uses proprietary screening to identify companies showing accelerating AI-related revenue growth, increased AI patent filings, and rising AI-focused R&D spending. Holdings are weighted by a composite score measuring AI revenue contribution and growth trajectory, with quarterly rebalancing to capture emerging winners. The strategy favors mid-to-large caps with proven AI monetization over speculative plays.
Key Features
- Focuses on AI revenue generation, not just AI exposure — excludes hype stocks without clear monetization
- Actively managed to adapt as AI winners emerge, unlike static tech indices
- Concentrated portfolio (typically 30-50 names) for meaningful exposure to AI inflection thesis
Risks
- AI bubble risk — if AI adoption disappoints, this concentrated bet could drop 40-60% like dot-com specialists
- Valuation compression — many AI beneficiaries trade at 50+ P/E ratios, vulnerable to rate hikes
- Winner-take-all dynamics — the fund could miss the eventual AI dominators if they emerge from outside current holdings
Who Should Own This
Best for growth investors who believe we're early in a multi-decade AI transformation and want concentrated exposure beyond just buying NVDA and MSFT. Works as a 5-10% satellite position for those willing to accept tech-bubble-level volatility in exchange for potential outperformance. Not suitable for anyone who needs this money in the next 3-5 years.